jrnl1400

Publication Venue For

  • Patient attitudes about non-medical switching to biosimilars: results from an online patient survey in the United States.  35:603-609. 2019
  • Physician attitudes about non-medical switching to biosimilars: results from an online physician survey in the United States.  35:611-617. 2019
  • Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studies.  35:1483-1493. 2019
  • Understanding concentrated insulins: a systematic review of randomized controlled trials.  34:1029-1043. 2018
  • Physician perceptions of pharmacologic treatment options for chorea associated with Huntington disease in the United States.  34:643-648. 2018
  • Long-term safety of tobramycin inhalation powder in patients with cystic fibrosis: phase IV (ETOILES) study.  32:1789-1795. 2016
  • Assessment of treatment and monitoring patterns and subsequent outcomes among patients with chronic myeloid leukemia treated with imatinib in a community setting.  30:529-536. 2014
  • Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension.  29:901-910. 2013
  • Injection-site burning and stinging in patients with rheumatoid arthritis using injectable biologics.  27:71-78. 2011
  • Menorrhagia Impact Questionnaire: Assessing the influence of heavy menstrual bleeding on quality of life.  26:2745-2755. 2010
  • Estimating a meaningful reduction in menstrual blood loss for women with heavy menstrual bleeding.  26:2673-2678. 2010
  • Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MS.  26:493-500. 2010
  • Effect of increased body mass index on asthma risk, impairment and response to asthma controller therapy in African Americans.  26:1629-1635. 2010
  • Analysis of the impact and burden of illness of adult chronic ITP in the US.  25:2961-2969. 2009
  • Core elements of epilepsy diagnosis and management: Expert consensus from the Leadership in Epilepsy, Advocacy, and Development (LEAD) faculty.  24:3463-3477. 2008
  • Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.  24:2303-2311. 2008
  • Asthma exacerbations in African Americans treated for 1 year with combination fluticasone propionate and salmeterol or fluticasone propionate alone.  24:1669-1682. 2008
  • A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension.  24:1101-1114. 2008
  • Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.  23:259-270. 2007
  • Single-day famciclovir therapy for recurrent genital herpes.  22:1307-1310. 2006